Trump’s new coronavirus vaccine czar owns $10 million in stock options in company developing vaccine | Salon.com
The former pharmaceutical executive named by President Donald Trump to lead a federal coronavirus vaccine development project owns more than $10 million in stock options in a company that has received federal funding to develop such a vaccine.
Trump last week announced that Moncef Slaoui, the former head of vaccine development at the pharmaceutical giant GlaxoSmithKline, would be the chief scientist for “Operation Warp Speed,” an administration initiative to speed up the process.
Slaoui stepped down from his position on the board of directors at Moderna, a Massachusetts-based pharmaceutical company which is already planning a clinical trial for a vaccine it developed, to take on the job. His White House position is unpaid, according to the Associated Press.
But Securities and Exchange Commission filings show that Slaoui still holds more than 150,000 stock options in Moderna.
Got Warp Speed corruption? The same people deciding which vaccine will be approved and mass marketed to billions are also the same ones that will profit from it…
Avalanches of money and absolute monopoly power guaranteed..